All In Biotech

Drug Trial Radar · NCT03199911

Topical Antibiotic Prophylaxis for Eyelids

The Role of Topical Antibiotic Prophylaxis in Eyelid Surgery

Last checked: Nov 19, 2026Latest source record: Jul 21, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 401 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

401

Actual

Start

Oct 2, 2017

Primary completion

Nov 14, 2019

Study completion Nov 14, 2019

Sponsor

Lead sponsor
University of California, San FranciscoAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 27, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The investigators propose a prospective randomized control trial testing the hypothesis that routine topical antibiotic prophylaxis does not significantly reduce the rate of infection after eyelid surgery.

Conditions

  • Antibiotic Side Effect
  • Eyelid; Wound
  • Eyelid Diseases
  • Surgical Wound Infection
  • Surgical Wound, Recent
  • Surgical Incision
  • Skin Cancer Face
  • Antibiotic Allergy
  • Surgical Site Infection

Interventions

  • Topical Antibiotic ProductDrug

    Topical antibiotic ointment will be erythromycin or bacitracin. If the patient cannot obtain either (e.g. lack of availability at the pharmacy), bacitracin polymyxin will be prescribed. Allergy to all 3 study drugs means that a patient will be excluded from the study.

  • Topical Non-Antibiotic OintmentDrug

    Mineral oil/petrolatum-based artificial tear ointment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Surgical Site InfectionsTime frame: First Post-Operative Visit (~7-14 days)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California, San Francisco

    San Francisco, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.